IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.27
+8.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 28.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -27.36x
- Price / sales
- 36.04x
- Price / cash flow
- -8.74x
Enterprise value
- Enterprise value
- $301.4M
- EV / sales
- 30.58x
- EV / EBITDA
- -2.87x
- EV / EBIT
- -5.95x
- Market cap
- $355.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026